CL2012002246A1 - Proceso para producir un extracto de alergenos; extracto de alergenos; uso de un extracto de alergenos para tratar alergia a los cacahuetes; composicion farmacéutica que comprende dicho extracto; vacuna que comprende un extracto de alergenos. - Google Patents

Proceso para producir un extracto de alergenos; extracto de alergenos; uso de un extracto de alergenos para tratar alergia a los cacahuetes; composicion farmacéutica que comprende dicho extracto; vacuna que comprende un extracto de alergenos.

Info

Publication number
CL2012002246A1
CL2012002246A1 CL2012002246A CL2012002246A CL2012002246A1 CL 2012002246 A1 CL2012002246 A1 CL 2012002246A1 CL 2012002246 A CL2012002246 A CL 2012002246A CL 2012002246 A CL2012002246 A CL 2012002246A CL 2012002246 A1 CL2012002246 A1 CL 2012002246A1
Authority
CL
Chile
Prior art keywords
extract
allergen extract
allergen
vaccine
produce
Prior art date
Application number
CL2012002246A
Other languages
English (en)
Inventor
Sanchez Jeronimo Carnes
Original Assignee
Leti Sl Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leti Sl Lab filed Critical Leti Sl Lab
Publication of CL2012002246A1 publication Critical patent/CL2012002246A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Insects & Arthropods (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Proceso para producir un extracto de alérgenos; extracto de alérgenos; uso de un extracto de alérgenos para tratar alergia a los cacahuetes; composición farmacéutica que comprende dicho extracto; vacuna que comprende un extracto de alérgenos.
CL2012002246A 2010-02-12 2012-08-13 Proceso para producir un extracto de alergenos; extracto de alergenos; uso de un extracto de alergenos para tratar alergia a los cacahuetes; composicion farmacéutica que comprende dicho extracto; vacuna que comprende un extracto de alergenos. CL2012002246A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201030199 2010-02-12

Publications (1)

Publication Number Publication Date
CL2012002246A1 true CL2012002246A1 (es) 2013-05-24

Family

ID=43760024

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012002246A CL2012002246A1 (es) 2010-02-12 2012-08-13 Proceso para producir un extracto de alergenos; extracto de alergenos; uso de un extracto de alergenos para tratar alergia a los cacahuetes; composicion farmacéutica que comprende dicho extracto; vacuna que comprende un extracto de alergenos.

Country Status (17)

Country Link
US (3) US9884111B2 (es)
EP (2) EP2533808B1 (es)
JP (3) JP5969922B2 (es)
CN (2) CN102821785B (es)
AU (1) AU2011214316B2 (es)
BR (1) BR112012019848B1 (es)
CA (2) CA3060638A1 (es)
CL (1) CL2012002246A1 (es)
CO (1) CO6602140A2 (es)
EC (1) ECSP12012102A (es)
ES (2) ES2395093T3 (es)
MX (1) MX2012009267A (es)
PE (1) PE20130044A1 (es)
PL (2) PL2853271T3 (es)
PT (2) PT2533808E (es)
RU (2) RU2572230C2 (es)
WO (1) WO2011098569A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2395093T3 (es) 2010-02-12 2014-12-22 Laboratorios Leti, S.L. Proceso para producir un extracto de alérgenos
LT2875828T (lt) * 2012-07-20 2019-07-25 Diater, Laboratorio de Diagnostico y Aplicaciones TerapĆ©uticas, S.A. Kompozicijos, skirtos polimerintų alergenų intraderminiam įvedimui
CN104447943A (zh) * 2014-11-21 2015-03-25 浙江我武生物科技股份有限公司 一种提取狗毛皮屑变应原的方法
JP7341138B2 (ja) * 2017-07-31 2023-09-08 レティ・ファルマ・ソシエダ・リミタダ 動物用製品
US11408895B1 (en) 2018-04-09 2022-08-09 Hob Biotech Group Corp., Ltd. Allergen characterization, potent allergen product formulation, comprehensive allergen reagent, and allergy assay
AU2019422413A1 (en) * 2019-01-17 2021-08-26 LETI Pharma S.L. Methods of purifying an allergen extract
CN113817037A (zh) * 2021-10-29 2021-12-21 南昌大学 一种从生腰果中制备高纯度致敏原Ana o 3的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2463740A (en) 1946-03-29 1949-03-08 Raymond S Burnett Preparation of peanut protein free from peanut skin pigment
GB1283989A (en) * 1969-12-15 1972-08-02 Omega Lab Ltd Allergenic extracts and method for their preparation
US4234569A (en) * 1978-10-04 1980-11-18 The Johns Hopkins University Production of aldehyde-treated allergen-containing substances
JPS5645417A (en) * 1979-09-19 1981-04-25 Mochida Pharmaceut Co Ltd Pharmaceutical composition having antiallergic activity
EP0083497A3 (en) * 1982-01-06 1985-11-06 Beecham Group Plc Process for preparing modified allergens, their use in treating allergic conditions
US4716120A (en) * 1983-03-17 1987-12-29 Minnesota Mining And Manufacturing Company Stable allergenic extracts and methods
ES2013359A6 (es) * 1988-11-04 1990-05-01 Corporacion Biolog Farmaceutic Procedimiento para la fabricacion de alergenos inmunogenicos polimerizados.
WO1992019970A1 (en) 1991-04-26 1992-11-12 Emanuel Calenoff Methods to detect and treat diseases caused by bacterial allergens
AU675629B2 (en) 1992-09-21 1997-02-13 Laboratorios Leti S.A. A process for the purification of aqueous extracts containing allergenically active proteins, extracts obtainable according to this process as well as their use
JP3397791B2 (ja) * 1992-09-21 2003-04-21 ラボラトリオス レティ ソシエダッド アノニマ アレルゲンとして活性なタンパク質を含有する水性エキスの精製方法，この方法で得られるエキスならびにそれらの使用
JP2005503113A (ja) * 2001-02-05 2005-02-03 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ブタクサアレルゲン
ES2869895T3 (es) * 2001-03-09 2021-10-26 Chugai Pharmaceutical Co Ltd Método de purificación de proteínas
RU2205661C2 (ru) * 2001-07-13 2003-06-10 Петров Рем Викторович Аллерготропин для лечения полинозов и способ лечения полинозов
CN1430052A (zh) * 2001-12-31 2003-07-16 合富生化科技股份有限公司 过敏原检测芯片
FR2841906B1 (fr) * 2002-07-05 2006-08-18 Stallergenes Sa Molecule d'acide nucleique codant une preproproteine d'allergene d'un acarien du genre dermatophagoides ou euroglyphus et son utilisation pour la production dudit allergene dans les plantes
ZA200504990B (en) * 2003-01-09 2006-08-30 Genentech Inc Purification of polypeptides
DE60301944T2 (de) 2003-01-21 2006-06-01 Biomay Produktions- Und Handels-Aktiengesellschaft Verfahren zur Vorbereitung von hypoallergenen Mosaikproteinen#
EP1834649A1 (en) 2006-03-14 2007-09-19 Alk-Abello A/S Method of developing a process for producing an allergen extract
DK1834648T3 (da) * 2006-03-14 2013-11-04 Alk Abello As Fremgangsmåde til fremstilling af et allergenekstrakt
US7887821B2 (en) * 2007-12-20 2011-02-15 Alk-Abello A/S Process for producing an allergen extract
ES2395093T3 (es) * 2010-02-12 2014-12-22 Laboratorios Leti, S.L. Proceso para producir un extracto de alérgenos

Also Published As

Publication number Publication date
US11246923B2 (en) 2022-02-15
BR112012019848A2 (pt) 2020-07-07
ES2676058T3 (es) 2018-07-16
US20150306211A1 (en) 2015-10-29
PL2853271T3 (pl) 2018-09-28
RU2572230C2 (ru) 2015-12-27
EP2533808A1 (en) 2012-12-19
ES2395093T3 (es) 2014-12-22
RU2012134032A (ru) 2014-03-20
JP2013519656A (ja) 2013-05-30
PE20130044A1 (es) 2013-02-14
RU2015149538A3 (es) 2019-05-08
US20180200363A1 (en) 2018-07-19
EP2853271A1 (en) 2015-04-01
ECSP12012102A (es) 2013-04-30
MX2012009267A (es) 2013-02-07
US20180200362A1 (en) 2018-07-19
AU2011214316A1 (en) 2012-08-16
PT2533808E (pt) 2014-11-28
EP2533808B1 (en) 2014-08-20
US9884111B2 (en) 2018-02-06
BR112012019848B1 (pt) 2022-03-15
JP2017226687A (ja) 2017-12-28
RU2706685C2 (ru) 2019-11-20
CN102821785B (zh) 2014-12-10
JP5969922B2 (ja) 2016-08-17
JP2016145235A (ja) 2016-08-12
RU2015149538A (ru) 2019-01-15
CN104371016A (zh) 2015-02-25
CN104371016B (zh) 2018-05-15
CO6602140A2 (es) 2013-01-18
EP2853271B1 (en) 2018-04-04
WO2011098569A1 (en) 2011-08-18
JP6646480B2 (ja) 2020-02-14
AU2011214316B2 (en) 2015-07-02
ES2395093T1 (es) 2013-02-08
CN102821785A (zh) 2012-12-12
CA2789174C (en) 2021-08-24
CA2789174A1 (en) 2011-08-18
PT2853271T (pt) 2018-07-09
PL2533808T3 (pl) 2015-03-31
WO2011098569A9 (en) 2012-03-15
CA3060638A1 (en) 2011-08-18

Similar Documents

Publication Publication Date Title
CL2012002246A1 (es) Proceso para producir un extracto de alergenos; extracto de alergenos; uso de un extracto de alergenos para tratar alergia a los cacahuetes; composicion farmacéutica que comprende dicho extracto; vacuna que comprende un extracto de alergenos.
CL2014001291A1 (es) Agentes de iarn de doble hebra; composiciones y metodos de uso de los mismos para tratar enfermedades asociadas con transtiretina (ttr).
CL2015003801A1 (es) Formulaciones de anticuerpos y metodos
AR091700A1 (es) Anticuerpos e inmunoconjugados anti-cd79b
BR112013018877A2 (pt) composições farmacêuticas que compreendem anticorpos humanos para pcsk9
PE20151067A1 (es) Inhibidores de autotaxina
CL2014000183A1 (es) Formulación farmacéutica que contienen anticuerpos anti-pcsk9; metodo para preparar dicha formulación.
CR20120184A (es) Anticuerpos monoclonales frente a progastrina y su usos
PE20150646A1 (es) Metodos de tratamiento de una tauopatia
UY35467A (es) Compuestos orgánicos
CR20130033A (es) Formulaciones de rifaximina y usos de las mismas
UY34782A (es) Anticuerpos humanos para fel d1 y métodos para usarlos.
CL2014002096A1 (es) Compuestos heterocíclicos que comprenden un sistema enediino; conjugados de los mismos; composiciones que los comprenden; y uso para tratar el cáncer
CO7020907A2 (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmacéuticas y métodos de uso de los mismos
CR20120449A (es) Formas de rifaximina y sus usos
BR112014009837A2 (pt) uso eficaz da levedura e extrato de levedura
BR112013031493A2 (pt) composto, composição farmacêutica, uso de um composto, combinação de um composto, dispositivo e processo de preparação de um composto.
BR112013029773A2 (pt) canabinoides para uso no tratamento de dor neuropática
CL2015002724A1 (es) Métodos para tratar la enfermedad de crohn utilizando un anticuerpo anti-il23
GT201400090A (es) 2-tiopirimidinonas
DOP2012000279A (es) Composiciones farmaceuticas que comprenden hidromorfona y naloxona
UY33909A (es) Metodo para producir fibra de lignina
ES2408343R1 (es) Composiciones farmacéuticas que comprenden hidromorfona y naloxona
CL2011002258A1 (es) Compuestos derivados heterociclicos fusionados; composicion farmaceutica que los comprende; y uso de los compuestos para tratar vih.
CL2013001129A1 (es) Composicion que comprende una celula madre gbm6-ad de glioblastoma purificada; metodo de generacion de anticuerpos especificos para gbm6-ad; dicho anticuerpo; metodo para producir una vacuna de celulas dendriticas; y su uso para el tratamiento de cancer.